Compare SNT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNT | VNRX |
|---|---|---|
| Founded | 1965 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 31.9M |
| IPO Year | 2023 | 2012 |
| Metric | SNT | VNRX |
|---|---|---|
| Price | $2.95 | $0.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.13 |
| AVG Volume (30 Days) | 18.6K | ★ 15.1M |
| Earning Date | 04-22-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,727,384.00 |
| Revenue This Year | N/A | $479.89 |
| Revenue Next Year | N/A | $536.25 |
| P/E Ratio | $19.22 | ★ N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $2.57 | $0.17 |
| 52 Week High | $5.34 | $0.94 |
| Indicator | SNT | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.16 | 38.02 |
| Support Level | $2.75 | $0.17 |
| Resistance Level | $3.16 | $0.32 |
| Average True Range (ATR) | 0.16 | 0.03 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 32.65 | 1.13 |
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.